Saxenda Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Liraglutide

Indications/Uses

Adjunct to reduced-calorie diet & increased physical activity for wt management in adult patients w/ initial BMI of ≥30 kg/m² (obese) or ≥27 kg/m² to <30 kg/m² (overwt) in the presence of at least 1 wt-related comorbidity eg, dysglycaemia (pre-diabetes or type 2 DM), HTN, dyslipidaemia or obstructive sleep apnoea. Adjunct to healthy nutrition & increased physical activity for wt management in adolescent patients ≥12 yr w/ inadequate response to reduced calorie diet & increased physical activity alone, obesity & body wt >60 kg.

Dosage/Direction for Use

SC Initially 0.6 mg once daily. May be increased to 3 mg once daily in increments of 0.6 mg w/ at least 1 wk interval. Maintenance dose: 3 mg. Max daily dose: 3 mg.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity.

MIMS Class

Anti-Obesity Agents / Antidiabetic Agents

ATC Classification

A10BJ02 - liraglutide ; Belongs to the class of glucagon-like peptide-1 (GLP-1) analogues. Used in the treatment of diabetes.

Regulatory Classification

POM

Presentation/Packing

Form

Saxenda soln for inj 6 mg/mL

Packing/Price

1's

Saxenda

liraglutide

Manufacturer:

Novo Nordisk A/S